Abstracts

Citation

Tapiwa Mbengeranwa, Lauren Ziemba, Benjamin Johnston, Haseena Cassim, Gerhard Theron, Z. Ngqawana, Deo Wabwire, Katie McCarthy, Nahida Chakhtoura, Patrick Jean-Philippe, John Shepherd, Shahin Lockman, Lameck Chinula, Lynda Stranix-Chibanda, IMPAACT 2010/VESTED Study Team and investigators. Bone mineral density/content of postpartum mothers taking treatment including DTG vs EFV, TDF vs TAF in pregnancy and their infants: randomized IMPAACT 2010 trial. Presented at: International Workshop on HIV Pediatrics; 2021 Jul 16.

Citation

Edmund Capparelli, Pharm.D., Alice M. Stek, M.D., Brookie M. Best, Pharm.D., Stephen J. Rossi, Pharm.D., Sandra K. Burchett, M.D., M.S., Haihong Li, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Elizabeth (Betsy) Smith, M.D., Elizabeth Hawkins, Michael T. Basar, B.S., Mark Mirochnick, M.D. Boosted FosAmprenavir Pharmacokinetics During Pregnancy. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Thomas Wilkinson, Kyle Nakamura, Laura Heath, Edwin Sobrera, William Decker, Katherine Semrau, Moses Sinkala, Chipepo Kankasa, Nicholas Webb, Benhur Lee, Donald Thea, Louise Kuhn, James Mullins, Grace Aldrovandi. Breast Milk and In Utero HIV-1 Transmission Select for Unique Envelope Signatures. Presented at: CROI 2016; 2016 Feb 23.

Citation

Tk Nguyen, Jung-Woo Chae, Lauren Ziemba, Anne Coletti, Kevin Knowles, Benjamin Johnston, Patrick Jean-Philippe, Tsungai Mhembere, Tariro Chawana, Deo Wabwire, Violet Korutaro, Shahin Lockman, Lameck Chinula, Jeremiah Momper, IMPAACT 2010/VESTED Protocol Team. Breast Milk Transfer and Infant Exposures to DTG, TAF, and TFV: Results from IMPAACT 2010/VESTED. Presented at: CROI 2024; 2024 Mar 04.

Citation

Genevieve Fouda, Coleen Cunningham, Elizabeth J. McFarland, William Borkowsky, Nicole Yates, Erika Kunz, Erin McGuire, Hua-Xin Liao, Barton Haynes, Georgia Tomaras, Sallie Permar. Broad, highly avid vaccine-elicited anti-V1V2 IgG responses in HIV-exposed infants. Presented at: CROI 2015; 2015 Feb 24.

Citation

Elizabeth J. McFarland, Edmund V. Capparelli, Mark J. Giganti, Kelly Seaton, Caroline Brackett, Charlotte Perlowski, Dwight E. Yin, Hans Spiegel, Jack Moye, Sai Majji, Paul A. Harding, Richard A. Koup, Georgia Tomaras, Coleen K. Cunningham, IMPAACT P1112 team. Broadly Neutralizing Antibodies in Oral Secretions After Administration to Newborns Exposed to HIV. Presented at: CROI 2026; 2026 Feb 25.

Citation

GR Campbell, RS Bruckman, YL Chu, SA Spector. Bystander Effect of Histone Deacetylase Inhibitors on HIV-1 Infection. Presented at: CROI 2015; 2015 Feb 25.

Citation

Yu-Wei Lin, S.Y. Amy Cheung, Isabelle Deprez, Susan Ford , Jon Collins, Cindy McCoig, Conn Harrington, Aditya Gaur, Carolyn Bolton, Lynda Stranix-Chibanda, Sybil Hosek, Mark Marzinke, Brookie Best, Edmund Capparelli, IMPAACT 2017 team. Cabotegravir PopPK Analysis of Adults & Adolescents Living with HIV or at Risk for HIV Receiving PrEP. Presented at: CROI 2024.

Citation

Lawrence D'Angelo, M.D., M.P.H., Donna Futterman, M.D., Jane C. Lindsey, Sc.D., Audrey S. Rogers, Ph.D., M.P.H., Mary Culnane, C.R.N.P., M.S., Bonnie Zimmer, B.S., Susan Abdalian, M.D. Can Adolescents Be Enrolled in AIDS Clinical Trials? The Results Of ACTG Protocol 220.

Citation

Can the Specimen Adequacy Control (SAC) in Cepheid Xpert® CT/NG predict infection?.